{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Acylated piperazine derivatives as melanocortin-4 receptor agonists", "item": "https://www.patentleaderboard.com/patent/7160886"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Acylated piperazine derivatives as melanocortin-4 receptor agonists

Acylated piperazine derivatives as melanocortin-4 receptor agonists

US Patent 7160886 · Granted Jan 9, 2007

Estimated economic value: $131,115,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Natriuretic peptide receptor a agonists useful for the treatment of cardiometabo2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
GPR40 agonists2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
PCSK9 antagonist compounds2024
Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024
Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024
Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors2024
Compounds for treating or inhibiting recurrence of acute myeloid leukemia2024
Inhibitors of cellular metabolic processes2024
AMPK activators2023
GPR119 agonists2022